Show
Sort by
-
A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
-
Independent risk factors for anemia in cancer patients receiving chemotherapy: Results from the European Cancer Anaemia Survey
-
Cancer-related anemia: Pathogenesis, prevalence and treatment
-
Cancer-related anemia: Biological findings, clinical implications and impact on quality of life
-
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
-
Ondansetron suppository: A randomised, double-blind, double-dummy, parallel-group comparison with oral ondansetron for the prevention of cyclophosphamide-induced emesis and nausea.
-
Effect of anticancer agents on invasion of mouse fibrosarcoma cells in vitro.
-
Methyl[5-(2-thienylcarbonyl)-1H-Benzimidazole-2-yl] Carbamate (R17934), a synthetic microtubule inhibitor, prevents malignant invasion in vitro.
-
Invasion of malignant cells into 51Cr-labeled host tissues in organotypical culture